Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MMS19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RPL5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C1orf21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
NUTM2B-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
C11orf95 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM67 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RALGPS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NDUFAF7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TIMM44 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP3K12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FUT9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZFYVE16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBL4A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNHG17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNORA16A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on